Neoadjuvant and Adjuvant Systemic Therapy for Newly Diagnosed Stage II–IV Epithelial Ovary, Fallopian Tube, or Primary Peritoneal Carcinoma: A Practice Guideline

Neoadjuvant and Adjuvant Systemic Therapy for Newly Diagnosed Stage II–IV Epithelial Ovary, Fallopian Tube, or Primary Peritoneal Carcinoma: A Practice Guideline

Background: This study aims to provide guidance for the use of neoadjuvant and adjuvant systemic therapy in women with newly diagnosed stage II–IV epithelial ovary, fallopian tube, or primary peritoneal carcinoma. Methods: EMBASE, MEDLINE, and Cochrane Library were investigated for relevant systemat...

Full description

Bibliographic Details
Main Authors: Hal Hirte, Raymond Poon, Xiaomei Yao, Taymaa May, Josee-Lyne Ethier, Lauri Petz, Jane Speakman, Laurie Elit
Format: Article
Language:English
Published: MDPI AG 2022-01-01
Series:Current Oncology
Subjects:
ovarian cancer
neoadjuvant therapy
adjuvant therapy
intraperitoneal therapy
cytoreductive surgery
clinical practice guideline
Online Access:https://www.mdpi.com/1718-7729/29/1/22

Internet

https://www.mdpi.com/1718-7729/29/1/22

Similar Items